InterCure Ltd.

ILA 10.46As of Sun 8 Nov 2026, 12:00 UTC
TASE:INCRHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR (1.35%)
Div yield —
ROE (9.27%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.73
PE TTM —
TSR TTM (54.67%)
Mkt cap ILS 123.9M
ROIC (12.62%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 13
24.08%
(83.78%)
Hold 6|9|1|7|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareILS
0.17
0.19
0.20
0.19
12.36%
16.29%
20.49%
11.38%
RevenueILS M
7.006
7.012
7.244
7.468
9.15%
5.79%
5.78%
9.68%
Peers (US$38.71M)
Cap (US$)
PE
39.45M
—
Capital
TTM
5Y
10Y
Leveragex
1.597
0.021
0.016
EBIT/Intx
0.250
0.416
0.385
Own earn%
(118.60)
28.96
41.17
Sh yield%
9.37
12.97
11.50
Owners
Insiders/Inst%
11.58
39.92
Short interest%
3.29
SBC / revenue%
5.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
1–7
$1 testx
0.1
Incr. ROIC%
35